Target intelligence / Profile preview

Plutonium (Pu)

Target
Pu
Molecular classification
Actinide, Transuranic element
01

Overview

Plutonium is a silvery-gray, radioactive metal belonging to the actinide series. It is primarily man-made, with trace amounts occurring naturally from uranium decay. Plutonium has fifteen known isotopes, with Plutonium-238 used in radioisotope thermoelectric generators and Plutonium-239 used in nuclear weapons and reactors. All isotopes of plutonium are radioactive and pose health risks due to their radiotoxicity.

02

Biological functions

Nuclear fuelRadioisotope thermoelectric generators
03

Safety considerations

RadioactivityRadiotoxicityHealth risks if inhaled or ingested

Beyond the preview

Go deeper on Plutonium (Pu).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plutonium (Pu).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call